Biomedical Textiles Market by Fiber Type (Biodegradable  Non-biodegradable)  Fabric Type (Woven  Non-woven)  Application (Non-implantable  Surgical Sutures)  and Region (North America  Europe  Asia Pacific  MEA  South America) - Global Forecast to 2022

Biomedical Textiles Market by Fiber Type (Biodegradable Non-biodegradable) Fabric Type (Woven Non-woven) Application (Non-implantable Surgical Sutures) and Region (North America Europe Asia Pacific MEA South America) - Global Forecast to 2022

MarketsandMarkets | ID: 1524178976810 | Published at: 2018-03-16 | Pages: 130

  • €4.785,63


“The biomedical textiles market is projected to grow at a CAGR of 5.7% from 2017 to 2022, in terms of value.”
The biomedical textiles market is estimated to be USD 10.99 billion in 2017 and is projected to reach USD 14.50 billion by 2022, at a CAGR of 5.7% between 2017 and 2022. The increasing demand for biomedical textiles in bandages, surgical sutures, implants, and extracorporeal devices is one of the most significant factors driving the growth of the biomedical textiles market. The rise in the number of aging population and the increasing number of surgeries have also contributed to the growth of the biomedical textiles market. However, the need for high R&D investments is restraining the growth of the biomedical textiles market.
“The non-woven fabric segment is projected to lead the biomedical textiles market during the forecast period.”
Based on fabric type, the non-woven fabric segment accounted for the major share of the biomedical textiles market in 2016 and is also projected to grow at the highest CAGR during the forecast period owing to the high demand from non-implantable applications, such as gauze, cohesive, adhesive, tubular, and triangular bandages. Non-woven fabrics are unique, high-tech, and engineered fabrics used across a wide range of applications and products. Increasing awareness and the benefits of using this fabric type in the healthcare industry is expected to propel its demand between 2017 and 2022.
“The non-implantable application segment is projected to grow at the highest CAGR during the forecast period.”
Based on application, the non-implantable segment of the biomedical textiles market is expected to register the highest CAGR between 2017 and 2022. The demand for biomedical textiles in the non-implantable application is mainly driven by an increase in consumption of wound care products, such as gauzes, adhesive bandages, cohesive bandages, and others. The increasing number of accidents and surgeries is driving the market for biomedical textiles in non-implantable applications.

“The non-biodegradable fiber segment is projected to grow at the highest CAGR during the forecast period.”
Based on fiber type, the non-biodegradable segment is estimated to dominate the biomedical textiles market in 2017. The dominance can be attributed to the growing demand for non-biodegradable fibers, such as polypropylene, polyethylene, polyamide, and polyester, in non-implantable applications. These fibers are also widely used in many surgical sutures, implants, and extracorporeal devices.

“The biomedical textiles market in the Asia Pacific region is projected to grow at the highest CAGR between 2017 and 2022.” The Asia Pacific (APAC) biomedical textiles market is projected to grow at the highest CAGR during the forecast period. Companies manufacturing biomedical textiles have ample growth opportunities in this market owing to the availability of cheap labor and raw materials. The consumption of biomedical textiles is also high in this region due to densely populated countries, such as India and China. Additionally, the increasing government expenditure on healthcare facilities and rising income are also propelling the growth of the biomedical textiles market in APAC. Furthermore, the initiative taken by the Indian government to indigenously manufacture products under the “Make in India” initiative, is also expected to contribute to the growth of the APAC biomedical textiles market. For instance, the state government of Gujarat (India) is setting two new Technical Textile (TT) zones to be developed in Ahmedabad and Surat districts. The growth in technical textiles will directly influence the growth of the biomedical textiles market in the APAC region. In the process of determining and verifying the market size for several segments and subsegments gathered through secondary research, extensive primary interviews have been conducted as follows: • By Company Type- Tier 1 – 10%, Tier 2 – 25%, and Tier 3 – 65% • By Designation- C level – 10%, Director level – 30%, and Others – 60% • By Region- Asia Pacific – 45%, North America – 20%, Europe – 15%, South America – 11%, and Middle East & Africa – 9% This report provides a comprehensive analysis of key companies listed below: • Royal DSM (Netherlands) • Covidien (Ireland) • Integra Life Sciences (US) • Johnson & Johnson (US) • Smith & Nephew (UK) • Medline Industries (US) • B. Braun Melsungen (Germany) • Cardinal Health (US) • Paul Hartmann (Germany) • BSN Medical (Germany)

Research Coverage
This report covers the biomedical textiles market and forecasts the size of the market till 2022. The report includes the segmentation of the biomedical textiles market based on fabric type, fiber type, application, and region. Porter’s five forces analysis and key market dynamics, such as drivers, restraints, challenges, and opportunities influencing the growth of the biomedical textiles market have been discussed in the report. The report also provides company profiles and competitive benchmarking of major players operating in the biomedical textiles market.

Benefits of Buying the Report:

The report is expected to help market leaders/new entrants in the biomedical textiles market in the following ways: • This report segments the biomedical textiles market and provides the closest approximation of revenues for the overall market and its subsegments across different verticals and regions. • The report helps stakeholders understand the pulse of the market and provides information on key drivers, restraints, challenges, and opportunities of the biomedical textiles market. This report is also expected to help stakeholders understand their competitors and gain insights into improving their position in the biomedical textiles market. The competitive landscape section includes an ecosystem of competitors and detailed information on new product developments, expansions & investments, agreements & partnerships, and acquisitions.

TABLE OF CONTENTS

1 INTRODUCTION 14

  • 1.1 OBJECTIVES OF THE STUDY 14
  • 1.2 MARKET DEFINITION 14
  • 1.3 MARKET SCOPE 15
    • 1.3.1 YEARS CONSIDERED FOR THE STUDY 15
  • 1.4 CURRENCY 16
  • 1.5 LIMITATIONS 16
  • 1.6 STAKEHOLDERS 16
    2 RESEARCH METHODOLOGY 17
  • 2.1 RESEARCH DATA 17
    • 2.1.1 SECONDARY DATA 18
      • 2.1.1.1 Key data from secondary sources 18
    • 2.1.2 PRIMARY DATA 19
      • 2.1.2.1 Key data from primary sources 19
      • 2.1.2.2 Key industry insights 20
      • 2.1.2.3 Breakdown of primary interviews 20
  • 2.2 MARKET SIZE ESTIMATION 21
    • 2.2.1 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 21
    • 2.2.2 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 22
  • 2.3 DATA TRIANGULATION 23
  • 2.4 ASSUMPTIONS 24
    3 EXECUTIVE SUMMARY 25
    4 PREMIUM INSIGHTS 30
  • 4.1 SIGNIFICANT OPPORTUNITIES IN THE BIOMEDICAL TEXTILES MARKET 30
  • 4.2 BIOMEDICAL TEXTILES MARKET, BY APPLICATION 30
  • 4.3 BIOMEDICAL TEXTILES MARKET, BY COUNTRY AND REGION 31
  • 4.4 US BIOMEDICAL TEXTILES MARKET, BY APPLICATION 32
  • 4.5 BIOMEDICAL TEXTILES MARKET ATTRACTIVENESS 32
    5 MARKET OVERVIEW 33
  • 5.1 INTRODUCTION 33
  • 5.2 MARKET DYNAMICS 33
    • 5.2.1 DRIVERS 34
      • 5.2.1.1 Rising number of surgeries 34
      • 5.2.1.2 Rapid growth in aging population 34
      • 5.2.1.3 High quality of biomedical textiles 34
      • 5.2.1.4 Growing need for advanced wound dressing material 35
    • 5.2.2 RESTRAINTS 35
      • 5.2.2.1 High R&D investments 35
    • 5.2.3 OPPORTUNITIES 35
      • 5.2.3.1 Development of smart biomedical textiles 35
      • 5.2.3.2 Growing demand from emerging markets 36
    • 5.2.4 CHALLENGES 36
      • 5.2.4.1 Increasing pricing pressure on market players 36
      • 5.2.4.2 Product marketing 37
  • 5.3 PORTER’S FIVE FORCES ANALYSIS 37
    • 5.3.1 THREAT OF NEW ENTRANTS 38
    • 5.3.2 THREAT OF SUBSTITUTES 38
    • 5.3.3 BARGAINING POWER OF SUPPLIERS 39
    • 5.3.4 BARGAINING POWER OF BUYERS 39
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY 40
  • 5.4 INDUSTRY OUTLOOK 40
    • 5.4.1 CONTRIBUTION OF THE HEALTHCARE INDUSTRY TO GDP 40
      6 BIOMEDICAL TEXTILES MARKET, BY FIBER TYPE 42
  • 6.1 INTRODUCTION 43
  • 6.2 NON-BIODEGRADABLE FIBER 44
    • 6.2.1 POLYPROPYLENE AND POLYETHYLENE 44
    • 6.2.2 COTTON 44
    • 6.2.3 VISCOSE 44
    • 6.2.4 POLYESTER 44
    • 6.2.5 POLYAMIDE 44
    • 6.2.6 OTHERS 44
      • 6.2.6.1 Polyurethane 44
      • 6.2.6.2 Polytetrafluoroethylene(PTFE) 44
  • 6.3 BIODEGRADABLE FIBER 46
    • 6.3.1 COLLAGEN 46
    • 6.3.2 CHITIN 46
    • 6.3.3 OTHERS 46
      7 BIOMEDICAL TEXTILES MARKET, BY FABRIC TYPE 47
  • 7.1 INTRODUCTION 48
  • 7.2 NON-WOVEN FABRIC 49
  • 7.3 WOVEN FABRIC 50
  • 7.4 OTHERS 50
    • 7.4.1 KNITTED & BRAIDED FABRICS 50
    • 7.4.2 HOLLOW FABRIC 50
      8 BIOMEDICAL TEXTILES MARKET, BY APPLICATION 52
  • 8.1 INTRODUCTION 53
  • 8.2 NON-IMPLANTABLE 54
    • 8.2.1 BANDAGES 54
  • 8.3 SURGICAL SUTURES 58
  • 8.4 OTHERS 61
    • 8.4.1 IMPLANTABLE 61
      • 8.4.1.1 Soft tissue implants 61
      • 8.4.1.2 Hard tissue implants 61
      • 8.4.1.3 Dental prosthesis 61
      • 8.4.1.4 Vascular devices 61
    • 8.4.2 EXTRACORPOREAL DEVICES 61
      9 BIOMEDICAL TEXTILES MARKET, BY REGION 66
  • 9.1 INTRODUCTION 67
  • 9.2 NORTH AMERICA 68
    • 9.2.1 US 70
    • 9.2.2 CANADA 70
    • 9.2.3 MEXICO 71
  • 9.3 EUROPE 72
    • 9.3.1 GERMANY 74
    • 9.3.2 FRANCE 75
    • 9.3.3 UK 76
    • 9.3.4 ITALY 76
    • 9.3.5 SPAIN 77
    • 9.3.6 REST OF EUROPE 77
  • 9.4 APAC 78
    • 9.4.1 CHINA 80
    • 9.4.2 JAPAN 80
    • 9.4.3 INDIA 81
    • 9.4.4 AUSTRALIA & NEW ZEELAND 81
    • 9.4.5 SOUTH KOREA 81
    • 9.4.6 SINGAPORE 82
    • 9.4.7 REST OF APAC 82
  • 9.5 SOUTH AMERICA 82
    • 9.5.1 BRAZIL 83
    • 9.5.2 ARGENTINA 84
    • 9.5.3 REST OF SOUTH AMERICA 84
  • 9.6 MEA 84
    • 9.6.1 SOUTH AFRICA 85
    • 9.6.2 SAUDI ARABIA 86
    • 9.6.3 UAE 86
    • 9.6.4 REST OF MEA 86
      10 COMPETITIVE LANDSCAPE 87
  • 10.1 OVERVIEW 87
  • 10.2 MARKET RANKING OF KEY PLAYERS, 2016 88
  • 10.3 COMPETITIVE SCENARIO 89
  • 10.4 NEW PRODUCT DEVELOPMENTS 89
  • 10.5 EXPANSIONS 90
  • 10.6 ACQUISITIONS 91
  • 10.7 AGREEMENTS & PARTNERSHIPS 92
    11 COMPANY PROFILES 93
    (Business overview, Products offered, Recent developments, SWOT analysis & MnM View)*
  • 11.1 ROYAL DSM N.V. 93
  • 11.2 MEDTRONIC PLC 96
  • 11.3 INTEGRA LIFESCIENCES CORPORATION 99
  • 11.4 JOHNSON & JOHNSON 102
  • 11.5 SMITH & NEPHEW PLC 105
  • 11.6 MEDLINE INDUSTRIES, INC. 108
  • 11.7 B. BRAUN MELSUNGEN AG 110
  • 11.8 CARDINAL HEALTH, INC. 113
  • 11.9 PAUL HARTMANN AG 116
  • 11.10 BSN MEDICAL (A PART OF SVENSKA CELLULOSA AKTIEBOLAGET SCA) 118
*Details on Business overview, Products offered, Recent developments, SWOT analysis & MnM View might not be captured in case of unlisted companies.
  • 11.11 OTHER COMPANIES 119
    • 11.11.1 ATEX TECHNOLOGIES 119
    • 11.11.2 ELKEM SILICONES 119
    • 11.11.3 BALLY RIBBON MILLS 119
    • 11.11.4 US BIODESIGN 119
    • 11.11.5 NITTO DENKO CORPORATION 119
    • 11.11.6 KIMBERLY-CLARK CORPORATION 119
    • 11.11.7 MÖLNLYCKE HEALTH CARE 120
    • 11.11.8 3M COMPANY 120
    • 11.11.9 AHLSTROM-MUNKSJÖ 120
  • 11.11.10 FREUDENBERG & CO. KOMMANDITGESELLSCHAFT 120
  • 11.11.11 SECANT GROUP, LLC 120
  • 11.11.12 MEISTER & CIE AG 120
    12 APPENDIX 121
  • 12.1 INSIGHTS FROM INDUSTRY EXPERTS 121
  • 12.2 DISCUSSION GUIDE 122
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 124
  • 12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 126
  • 12.5 AVAILABLE CUSTOMIZATIONS 127
  • 12.6 RELATED REPORTS 127
  • 12.7 AUTHOR DETAILS 128

LIST OF TABLES

TABLE 1 HEALTHCARE EXPENDITURE OF COUNTRIES IN APAC 40
TABLE 2 HEALTHCARE EXPENDITURE OF COUNTRIES IN NORTH AMERICA 41
TABLE 3 HEALTHCARE EXPENDITURE OF COUNTRIES IN EUROPE 41
TABLE 4 HEALTHCARE EXPENDITURE OF COUNTRIES IN SOUTH AMERICA 41
TABLE 5 HEALTHCARE EXPENDITURE OF COUNTRIES IN MEA 41
TABLE 6 BIOMEDICAL TEXTILES MARKET SIZE, BY FIBER TYPE, 2015–2022 (USD MILLION) 43
TABLE 7 NON-BIODEGRADABLE FIBER MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 45
TABLE 8 BIODEGRADABLE FIBER MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 46
TABLE 9 BIOMEDICAL TEXTILES MARKET SIZE, BY FABRIC TYPE,
2015–2022 (USD MILLION) 48
TABLE 10 NON-WOVEN FABRIC MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 49
TABLE 11 WOVEN FABRIC MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 50
TABLE 12 OTHER FABRICS MARKET SIZE , BY REGION, 2015–2022 (USD MILLION) 51
TABLE 13 BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 53
TABLE 14 BIOMEDICAL TEXTILES MARKET SIZE IN NON-IMPLANTABLE APPLICATION,
BY REGION, 2015–2022 (USD MILLION) 54
TABLE 15 NORTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE IN NON-IMPLANTABLE APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION) 55
TABLE 16 EUROPE: BIOMEDICAL TEXTILES MARKET SIZE IN NON-IMPLANTABLE APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION) 55
TABLE 17 APAC: BIOMEDICAL TEXTILES MARKET SIZE IN NON-IMPLANTABLE APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 56
TABLE 18 SOUTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE IN NON-IMPLANTABLE APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION) 56
TABLE 19 MEA: BIOMEDICAL TEXTILES MARKET SIZE IN NON-IMPLANTABLE APPLICATION,
BY COUNTRY, 2015–2022 (USD MILLION) 57
TABLE 20 BIOMEDICAL TEXTILES MARKET SIZE IN SURGICAL SUTURES APPLICATION,
BY REGION, 2015–2022 (USD MILLION) 58
TABLE 21 NORTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE IN SURGICAL SUTURES APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION) 59
TABLE 22 EUROPE: BIOMEDICAL TEXTILES MARKET SIZE IN SURGICAL SUTURES APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION) 59
TABLE 23 APAC: BIOMEDICAL TEXTILES MARKET SIZE IN SURGICAL SUTURES APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION) 60
TABLE 24 SOUTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE IN SURGICAL SUTURES APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION) 60
TABLE 25 MEA: BIOMEDICAL TEXTILES MARKET SIZE IN SURGICAL SUTURES APPLICATION, BY COUNTRY, 2015–2022 (USD MILLION) 60
TABLE 26 BIOMEDICAL TEXTILES MARKET SIZE IN OTHER APPLICATIONS, BY REGION,
2015–2022 (USD MILLION) 62
TABLE 27 NORTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE IN OTHER APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 63
TABLE 28 EUROPE: BIOMEDICAL TEXTILES MARKET SIZE IN OTHER APPLICATIONS,
BY COUNTRY, 2015–2022 (USD MILLION) 63
TABLE 29 APAC: BIOMEDICAL TEXTILES MARKET SIZE IN OTHER APPLICATIONS,
BY COUNTRY, 2015–2022 (USD MILLION) 64
TABLE 30 SOUTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE IN OTHER APPLICATION,
BY COUNTRY, 2015–2022 (USD MILLION) 64
TABLE 31 MEA: BIOMEDICAL TEXTILES MARKET SIZE IN OTHER APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 65
TABLE 32 BIOMEDICAL TEXTILES MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 67
TABLE 33 NORTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE, BY FIBER TYPE,
2015–2022 (USD MILLION) 69
TABLE 34 NORTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 69
TABLE 35 NORTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE, BY COUNTRY,
2015–2022 (USD MILLION) 69
TABLE 36 US: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 70
TABLE 37 CANADA: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 71
TABLE 38 MEXICO: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 71
TABLE 39 EUROPE: BIOMEDICAL TEXTILES MARKET SIZE, BY FIBER TYPE,
2015–2022 (USD MILLION) 73
TABLE 40 EUROPE: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 73
TABLE 41 EUROPE: BIOMEDICAL TEXTILES MARKET SIZE, BY COUNTRY,
2015–2022 (USD MILLION) 74
TABLE 42 GERMANY: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 74
TABLE 43 FRANCE: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 75
TABLE 44 UK: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 76
TABLE 45 ITALY: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 77
TABLE 46 SPAIN: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 77
TABLE 47 APAC: BIOMEDICAL TEXTILES MARKET SIZE, BY FIBER TYPE,
2015–2022 (USD MILLION) 79
TABLE 48 APAC: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 79
TABLE 49 APAC: BIOMEDICAL TEXTILES MARKET SIZE, BY COUNTRY,
2015–2022 (USD MILLION) 79
TABLE 50 CHINA: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 80
TABLE 51 JAPAN: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 80
TABLE 52 INDIA: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION,
2015–2022 (USD MILLION) 81
TABLE 53 SOUTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE, BY FIBER TYPE,
2015—2022 (USD MILLION) 82
TABLE 54 SOUTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION,
2015—2022 (USD MILLION) 83
TABLE 55 SOUTH AMERICA: BIOMEDICAL TEXTILES MARKET SIZE, BY COUNTRY,
2015—2022 (USD MILLION) 83
TABLE 56 MEA: BIOMEDICAL TEXTILES MARKET SIZE, BY FIBER TYPE,
2015—2022 (USD MILLION) 84
TABLE 57 MEA: BIOMEDICAL TEXTILES MARKET SIZE, BY APPLICATION,
2015—2022 (USD MILLION) 85
TABLE 58 MEA: BIOMEDICAL TEXTILES MARKET SIZE, BY COUNTRY,
2015—2022 (USD MILLION) 85
TABLE 59 NEW PRODUCT DEVELOPMENTS, 2016–2018 89
TABLE 60 EXPANSIONS, 2016-2018 90
TABLE 61 ACQUISITIONS, 2016-2018 91
TABLE 62 AGREEMENTS & PARTNERSHIPS, 2016-2018 92


LIST OF FIGURES

FIGURE 1 BIOMEDICAL TEXTILES MARKET SEGMENTATION 15
FIGURE 2 BIOMEDICAL TEXTILES MARKET: RESEARCH DESIGN 17
FIGURE 3 BIOMEDICAL TEXTILES MARKET: DATA TRIANGULATION 23
FIGURE 4 NON-WOVEN FABRIC TO LEAD THE BIOMEDICAL TEXTILES MARKET BETWEEN 2017 AND 2022 25
FIGURE 5 NON-IMPLANTABLE TO BE THE FASTEST-GROWING APPLICATION OF BIOMEDICAL TEXTILES BETWEEN 2017 AND 2022 26
FIGURE 6 NON-BIODEGRADABLE FIBER TO LEAD THE BIOMEDICAL TEXTILES MARKET DURING THE FORECAST PERIOD 27
FIGURE 7 CHINA TO REGISTER THE HIGHEST CAGR IN THE BIOMEDICAL TEXTILES MARKET DURING THE FORECAST PERIOD 27
FIGURE 8 APAC TO BE THE FASTEST-GROWING BIOMEDICAL TEXTILES MARKET DURING
THE FORECAST PERIOD 28
FIGURE 9 THE BIOMEDICAL TEXTILES MARKET TO REGISTER SIGNIFICANT CAGR
BETWEEN 2017 AND 2022 30
FIGURE 10 NON-IMPLANTABLE TO BE THE LARGEST APPLICATION OF BIOMEDICAL TEXTILES DURING THE FORECAST PERIOD 30
FIGURE 11 US ACCOUNTED FOR THE LARGEST BIOMEDICAL TEXTILES MARKET SHARE
IN 2016 31
FIGURE 12 NON-IMPLANTABLE APPLICATION TO ACCOUNT FOR THE LARGEST SHARE BETWEEN 2017 AND 2022 32
FIGURE 13 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 32
FIGURE 14 OVERVIEW OF FACTORS GOVERNING THE BIOMEDICAL TEXTILES MARKET 33
FIGURE 15 PORTER’S FIVE FORCES ANALYSIS 37
FIGURE 16 NON-BIODEGRADABLE FIBER TO DOMINATE THE BIOMEDICAL TEXTILES MARKET BETWEEN 2017 AND 2022 43
FIGURE 17 NORTH AMERICA TO BE THE LARGEST MARKET FOR NON-BIODEGRADABLE FIBER BETWEEN 2017 AND 2022 45
FIGURE 18 NON-WOVEN FABRIC TO DOMINATE THE BIOMEDICAL TEXTILES MARKET
BETWEEN 2017 AND 2022 48
FIGURE 19 APAC TO BE THE FASTEST-GROWING NON-WOVEN FABRIC MARKET
BETWEEN 2017 AND 2022 49
FIGURE 20 NORTH AMERICA TO BE THE LARGEST MARKET FOR OTHER FABRICS
BETWEEN 2017 AND 2022 51
FIGURE 21 NON-IMPLANTABLE TO BE THE LARGEST APPLICATION OF BIOMEDICAL TEXTILES BETWEEN 2017 AND 2022 53
FIGURE 22 APAC TO BE THE LARGEST BIOMEDICAL TEXTILES MARKET IN SURGICAL SUTURES APPLICATION BETWEEN 2017 AND 2022 58
FIGURE 23 NORTH AMERICA TO BE THE LARGEST BIOMEDICAL TEXTILES MARKET IN OTHER APPLICATIONS BETWEEN 2017 AND 2022 62
FIGURE 24 US LEADS THE BIOMEDICAL TEXTILES MARKET 68
FIGURE 25 GERMANY TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 72
FIGURE 26 CHINA DOMINATES THE BIOMEDICAL TEXTILES MARKET 78
FIGURE 27 COMPANIES ADOPTED NEW PRODUCT DEVELOPMENTS AS THE KEY GROWTH STRATEGY BETWEEN 2016 AND 2018 87  
FIGURE 28 ROYAL DSM N.V.: COMPANY SNAPSHOT 93
FIGURE 29 MEDTRONIC PLC: COMPANY SNAPSHOT 96
FIGURE 30 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT 99
FIGURE 31 JOHNSON & JOHNSON: COMPANY SNAPSHOT 102
FIGURE 32 SMITH & NEPHEW PLC: COMPANY SNAPSHOT 105
FIGURE 33 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2016) 110
FIGURE 34 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT 113
FIGURE 35 PAUL HARTMANN AG: COMPANY SNAPSHOT 116

Get in touch!

Looking for sample pages? Or want to speak to someone about discounts?

Please leave your details and we'll get back to you as soon as we can!